Goal of the analysis:
Evaluate how a medical device will be covered, coded, and reimbursed by payers (for example, Medicare, private insurers, national health systems). Determine optimal coding pathways, payment rates, and documentation requirements to facilitate market adoption and revenue generation.
Data required:
- Current procedural terminology (CPT), Healthcare Common Procedure Coding System (HCPCS), or other relevant coding structures
- Payer policies, coverage guidelines, and local coverage determinations (LCDs)
- Medicare fee schedules or national healthcare system reimbursement schedules
- Competitor or predicate device reimbursement data for comparison
- Clinical and economic evidence supporting device use
- Documentation requirements (for example, prior authorization forms, medical necessity guidelines)
Detailed step-by-step instruction on how to conduct the analysis:
- Identify existing codes and coverage policies. Research whether existing CPT, HCPCS, or other local codes apply to your device. Check payer databases for coverage policies.
- Determine if a new code is needed. Assess whether current codes adequately describe the device or if you should pursue a new code application through the AMA CPT Editorial Panel or other authorities.
- Analyze reimbursement rates. Compare national and local payer fee schedules to understand how payment varies by region and provider setting (for example, inpatient, outpatient).
- Review supporting clinical and economic evidence. Evaluate whether existing studies or health economic models demonstrate cost-effectiveness and medical necessity, which can improve coverage likelihood.
- Assess payer coverage criteria. Determine if prior authorization, proof of medical necessity, or specific patient selection criteria are required for reimbursement.
- Benchmark against competitor or predicate devices. Identify how similar products are coded, reimbursed, and covered, noting any best practices or pitfalls.
- Develop a reimbursement strategy. Outline recommended coding, coverage goals, and documentation requirements for providers. Identify potential barriers and risk mitigation steps.
- Plan stakeholder education. Create materials to inform healthcare providers, billing teams, and patients on the correct use of codes and coverage processes.
Format of the output of analysis:
- A written reimbursement strategy document summarizing coding options, payment rates, and coverage requirements
- A comparison table highlighting competitor/predicate device reimbursement pathways and fee schedules
- A gap analysis noting any missing clinical or economic data needed to achieve favorable coverage
- An action plan with timelines for any required code applications, payer negotiations, or clinical data collection
How to interpret results:
- Clear alignment between the device’s clinical benefits and payer coverage criteria can facilitate smooth reimbursement.
- Gaps in coding, insufficient economic evidence, or a lack of coverage policies may delay adoption and limit revenue potential.
- Variations in payment rates across regions and payers may influence market prioritization and commercialization strategies.
Steps a company can take to improve on this measure:
- Engage with payers early to understand coverage expectations and gather feedback on clinical/economic evidence needs.
- Invest in robust health economics and outcomes research (HEOR) to demonstrate cost-effectiveness and justify favorable reimbursement.
- Provide clear coding guidance to providers, including billing templates and medical necessity documentation checklists.
- Monitor ongoing policy changes at both national and local levels, updating internal reimbursement strategies accordingly.
- Collaborate with industry associations, patient advocacy groups, or professional societies to advocate for new or revised codes.
Request the PDF Download of How to Analyze a Medical Devices Company
Menu of the analyses:
Table of Contents
A. Regulatory & Compliance
- Regulatory Pathway Analysis
- Regulatory Compliance and Quality Management Systems Review
- Labeling and Unique Device Identification (UDI) Compliance Assessment
- Device Classification and Product Code Analysis
- Combination Product Regulatory Strategy
- EU MDR/IVDR Compliance Gap Analysis
- MDSAP (Medical Device Single Audit Program) Readiness and Gap Analysis
- OTC vs. Prescription Device Classification Feasibility
- Reprocessing and Re-Manufacturing Compliance Assessment
- Software Update Lifecycle (IEC 62304) Compliance Review
B. Clinical & Post-Market
- Clinical Evidence Review
- Post-Market Surveillance and Vigilance
- CRO and Clinical Site Management Efficiency Analysis
- Real-World Evidence Generation Strategy for Device Performance
- Clinical Evidence Gap Analysis
- Comparative Efficacy and Safety Benchmarking vs. Standard of Care
- Field Safety Corrective Action and Recall Readiness Evaluation
- Patient Engagement and Compliance Tracking for Home-Use Devices
C. Reimbursement & Market Access
D. Product Development & Lifecycle
E. Operations & Supply Chain
F. Risk Management & Quality
G. Commercial Strategy & Marketing
H. Technology & Innovation
- Software as a Medical Device (SaMD) and Cybersecurity Risk Assessment
- Device Tracking and Traceability Program Analysis
- Human Factors Engineering and Usability Evaluation
- Material Compatibility and Biomaterial Selection Analysis
- Clinical Data Integration with Wearables and IoT Devices
- Calibration and Maintenance Program for Reusable Devices
- In-Vitro Diagnostic (IVD) Connectivity with Laboratory Information Systems (LIS) Workflow Analysis
- Remote Servicing and Maintenance Approach for Connected Medical Devices
I. Intellectual Property
J. Sustainability & Environmental Impact